Px Wire January-March 2009, Vol. 2, No. 1

PxWire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. Highlights in this issue of PxWire include a report on data from the Step vaccine trial and animal studies of relevance to the proposed HVTN 505 trial of the NIH Vaccine Research Center DNA-Ad5 combination strategy presented at the Keystone Symposium on HIV prevention–an annual meeting focused on basic and preclinical science. This issue also reviews newly launched trials, lays out this year’s upcoming trial milestones, and gives information on ordering the 2009 AVAC report on the prevention research field, to be released in May.